Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
Saved in:
| Title: | Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. |
|---|---|
| Authors: | Held C; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden claes.held@ucr.uu.se.; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., White HD; Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand., Stewart RAH; Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand., Budaj A; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland., Cannon CP; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA., Hochman JS; Department of Medicine, NYU Langone Medical Center, New York, NY., Koenig W; Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany.; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany., Siegbahn A; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden., Steg PG; Département Hospitalo-Universitaire FIRE, AP-HP, Hôpital Bichat, Paris, France.; Paris Diderot University Sorbonne Paris Cité, Paris, France.; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom.; FACT (French Alliance for Cardiovascular Trials), an F-CRIN network, INSERM U1148, Paris, France., Soffer J; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, Collegeville, PA., Weaver WD; Henry Ford Heart and Vascular Institute, Detroit, MI., Östlund O; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Wallentin L; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. |
| Corporate Authors: | STABILITY Investigators |
| Source: | Journal of the American Heart Association [J Am Heart Assoc] 2017 Oct 24; Vol. 6 (10). Date of Electronic Publication: 2017 Oct 24. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29066452 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Held+C%22">Held C</searchLink>; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden claes.held@ucr.uu.se.; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22White+HD%22">White HD</searchLink>; Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Stewart+RAH%22">Stewart RAH</searchLink>; Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Budaj+A%22">Budaj A</searchLink>; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Cannon+CP%22">Cannon CP</searchLink>; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Hochman+JS%22">Hochman JS</searchLink>; Department of Medicine, NYU Langone Medical Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Koenig+W%22">Koenig W</searchLink>; Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany.; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Siegbahn+A%22">Siegbahn A</searchLink>; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Steg+PG%22">Steg PG</searchLink>; Département Hospitalo-Universitaire FIRE, AP-HP, Hôpital Bichat, Paris, France.; Paris Diderot University Sorbonne Paris Cité, Paris, France.; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom.; FACT (French Alliance for Cardiovascular Trials), an F-CRIN network, INSERM U1148, Paris, France.<br /><searchLink fieldCode="AU" term="%22Soffer+J%22">Soffer J</searchLink>; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, Collegeville, PA.<br /><searchLink fieldCode="AU" term="%22Weaver+WD%22">Weaver WD</searchLink>; Henry Ford Heart and Vascular Institute, Detroit, MI.<br /><searchLink fieldCode="AU" term="%22Östlund+O%22">Östlund O</searchLink>; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Wallentin+L%22">Wallentin L</searchLink>; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22STABILITY+Investigators%22">STABILITY Investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101580524%22">Journal of the American Heart Association</searchLink> [J Am Heart Assoc] 2017 Oct 24; Vol. 6 (10). <i>Date of Electronic Publication: </i>2017 Oct 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101580524 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2047-9980 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220479980%22">20479980 </searchLink><i>NLM ISO Abbreviation: </i>J Am Heart Assoc <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29066452 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1161/JAHA.116.005077 Languages: – Code: eng Text: English Titles: – TitleFull: Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Held C – PersonEntity: Name: NameFull: White HD – PersonEntity: Name: NameFull: Stewart RAH – PersonEntity: Name: NameFull: Budaj A – PersonEntity: Name: NameFull: Cannon CP – PersonEntity: Name: NameFull: Hochman JS – PersonEntity: Name: NameFull: Koenig W – PersonEntity: Name: NameFull: Siegbahn A – PersonEntity: Name: NameFull: Steg PG – PersonEntity: Name: NameFull: Soffer J – PersonEntity: Name: NameFull: Weaver WD – PersonEntity: Name: NameFull: Östlund O – PersonEntity: Name: NameFull: Wallentin L IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 10 Text: 2017 Oct 24 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 2047-9980 Numbering: – Type: volume Value: 6 – Type: issue Value: 10 Titles: – TitleFull: Journal of the American Heart Association Type: main |
| ResultId | 1 |
